Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0300
-0.0045
(-13.04%)
At close: February 21 at 3:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-1,009.0040
-1,321.0470
-1,452.5620
-4,434.4650
-2,812.0010
Financing Cash Flow
890
1,250
1,125.2450
4,529.2150
3,224.0560
End Cash Position
169.0180
190.4050
261.4520
588.7690
494.0190
Income Tax Paid Supplemental Data
--
1.6000
--
--
0.8000
Interest Paid Supplemental Data
375.6350
390.5610
397.9950
299.3650
52.0660
Issuance of Capital Stock
--
--
158.8200
1,965.3450
2,929.0560
Issuance of Debt
915
1,410
966.4250
2,973.3750
345
Repayment of Debt
--
--
--
-407.5000
--
Repurchase of Capital Stock
--
-125
--
--
--
Free Cash Flow
-1,009.0040
-1,321.0470
-1,452.5620
-4,434.4650
-2,812.0010
12/31/2020 - 8/26/1993
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CPMV Mosaic ImmunoEngineering, Inc.
0.9800
+48.04%
SEELQ Seelos Therapeutics, Inc.
0.0003
+200.00%
IMUC EOM Pharmaceuticals Holdings, Inc.
0.1570
+53.77%
CSCI COSCIENS Biopharma Inc.
2.7200
-1.45%
ARDS Aridis Pharmaceuticals, Inc.
0.0001
0.00%
VANI Vivani Medical, Inc.
1.1500
-2.54%
PRLD Prelude Therapeutics Incorporated
0.8709
-3.50%
CARM Carisma Therapeutics, Inc.
0.4502
-2.72%
ENLV Enlivex Therapeutics Ltd.
1.0000
-0.99%
ENTA Enanta Pharmaceuticals, Inc.
8.03
-4.18%